Despite notable therapeutic avdvances in many areas of psychiatry, the progressive dementi as remain refractory. However, much new research has been stimulated by the recent acceptance of the view that a major cause of senile dementia is related to a pathological process indistinguishable from the less common presenile dementia of Alzheimer's type. The directions and implications of this work, as viewed by one group of investigators, are the subject of this review.
Alzheimer's disease is associated with several brain changes ( Table 1) . Consideration of this pathology has suggested three main hypotheses concerning the nature of the underlying disease process: 1) an incomplete or unconventional viral infection, 2) a disorder of the immune system and 3) a neurotoxic effect of a common environmental agent, aluminum. Each hypothesis is supported by considerable circumstantial evidence and a complete understanding of this disease will perhaps require knowledge of the interactions of these processes.
Viral Hypothesis
Neurofibrillary degeneration is a charac-teristic finding in Alzheimer's disease. This change is found in a variety of human brain conditions and may well be the result of a non-specific morphological response to a number of pathogenic agents. One of the events responsible for neurofibrillary degeneration may be the delayed expression of a conventional viral infection. Neurofibrillary degeneration occurs in brain stem nuclei, particularly in the substantia nigra, many years after epidemic encephalitis lethargica (7, 9) . While a pathogenic agent in this condition has not been identified, the neuropathology of acute cases was typical of a viral encephalitis, and post-encephalitic Parkinson's disease may be the delayed expression of a viral infection. Alzheimer neurofibrillary degeneration in cerebral cortex has also been reported in two. types of slow viral infections of the brain: progressive multifocal leukoencephalopathy (8) and subacute sclerosing panencephalitis (14, 15) . In the former condition, alterations in the immune system of the host appears to permit the proliferation of an otherwise benign virus. In subacute sclerosing panencephalitis, there is an apparently incomplete suppression of a measles-like paramyxovirus I. Cerebral Atrophy 2. Neuron loss 3. Altereddendritic configuration 4. Hippocampal granulovacuolar degeneration Can. Psychlatr. Assoc. J. Vol. 23 (1978) which permits slow replication of the agent and destruction of oligodendiolia resulting in progressive demyelination. Mandybur et aI. fifteen-year-old boy who died following sub-acute sclerosing panencephalitis. However, despite the circumstantial evidence implicating viruses, repeated attempts to transmit to laboratory animals an encephalopathy with the characteristic pathological changes of Alzheimer's disease have failed. Nevertheless, work in our laboratory has recently resulted in the induction in human fetal cerebral neurons, in vitro, of changes which are identical to those found in Alzheimer's neurofibrillary degeneration (5) . The ultrastructural subunits of Alzheimer neurofibrillary degeneration are aggregates of pairs of 1OOA 0 diameter filaments wound in a helical configuration (13, 20) . Human fetal neurons exposed to a saline extract prepared from Alzheimer affected brain develop, after fifteen days, filaments which have a similar configuration (5) . The exact significance of the' induction of the paired helical filaments in fetal neurons following exposure to an Alzheimer extract is unclear at present. An induction time of fifteen to thirty-five days in culture is in keeping with a process possibly related to a conventional viral infection, perhaps released in the absence of a complete immune system. A morphological survey of the tissue culture system in which paired helical filaments occurred revealed several types of particles which may be of viral origin, but definite identification awaits further study.
An alternative possibility explaining the induction of paired helical filaments in the model system by an Alzheimer brain extract is that the extract contained an assembly factor, perhaps a relatively stable molecule which binds to neurofilaments such that, under certain conditions within the neuron, pairs of filaments crossbond and assume a helical configuration. A crossbinding agent of this type may have arisen as a consequence of the primary neuronal degeneration, or as a viral product. Perhaps the most important future application of this in vitro model system will be the ability to test a variety of hypotheses which may playa role in the origin of neurofibrillary degeneration.
The chemical composition of the filamentous proteins which compose the human neurofibrillary material resembles, in part, both the proteins of the normal occurring 1OOA 0 neurofilaments and a constituent of the microtubules, f3 tubulin (l 0).
In areas of neurofibrillary degeneration, particularly in dendrites, there is a marked reduction in the number of microtubules. In the human neuron explant model, the paired helical structures often appear to be assembled from filaments which may have already been present in the cytoplasm. Generally, the paired helical filaments occurred in the experimental system in neural processes which appeared markedly distended by poorly staining cytosol and in which microtubules were fragmented and reduced in number. These zones of distended neural processes were occasionally seen to arise from short segments from an otherwise normal appearing process. This suggests the presence of an agent which may cause a local disturbance within the neuron, perhaps in microtubules or cytoplasmic flow. Since the loss of rnicrotubules appears to be associated with a zone of Alzheimer neurofibrillary degeneration, the possibility that a viral product may result in both the breakdown of microtubules and the assembly of paired helical filaments must be considered.
The neuritic or senile plaque is also an important morphological change which occurs in Alzheimer's disease. Laboratory production of this pathological change has not yet been achieved from Alzheiraer brain extracts. However, brain material affected with the unconventional agent of scrapie induces a pathological change in mouse brain closely resembling senile plaques with amyloid cores (3, 19) . Scrapie is a degenerative brain disease of sheep and resembles, pathologically, the transmissible human dementias of Creutzfeldt-Jakob disease and Kuru (6) . These transmissible agents differ in several ways from conventional viruses: they do not induce viral associated inflammatory response in the brain or alter cerebral spinal fluid cell count or protein. Furthermore, these agents are not associated with viral particles nor do they induce a systemic immune response.
In Alzheimer's disease, senile plaques and neurofibrillary degeneration generally occur together in the same brain. However, in the senile form of the disease, plaques may be more prevalent than neurons with neurofibrillary' degeneration. In addition, there are several conditions in which neurofibrillary degeneration occurs without senile plaques; for example, dementia pugilistica and the Guam Parkinson dementia complex. It is possible that senile plaques and neurofibrillary degeneration have different origins. Based on the meager evidence currently available it is not unreasonable to tentatively consider that an incomplete or partial expression of a conventional virus may be important in the formation of neurofibrillary degeneration and an unconventional agent may be important in the formation of senile plaques in Alzheimer's disease. Furthermore, the expression of these processes may depend on alterations in the immune system.
Immunological Considerations
Alterations in indices of immunological function might be expected in either persistent viral infections of the brain or in the presence of altered brain autoimmunity. Several studies argue against a significant ,role of antibodies toward normal brain in the serum of patients with Alzheimer's disease (16, 18) .
However, immunological techniques have demonstrated the presence of immunoglobulin deposited on amyloid fibrils within senile plaques (11). This suggests the presence of an abnormal antigen in Alzheimer affected brain and one of the most important goals in the next few years will be to identify the nature and origin of this antigen.
Although studies of serum protein including immunoglobulins in Alzheimer's disease have indicated alterations compatible with a persistent viral infection (2, 12) , the precise origin of the changes is unclear. However, taken together, the viral and immunological evidence support the possibility that an unconventional virus or an incomplete ex.pression of a conventional virus may be involved in the pathogenesis of Alzheimer's disease. The postulated agent only weakly excites an immune response and specific alterations in the immune system have not yet been detected which ex.plain the expression or susceptibility of an individual to the disease.
Aluminum as a Cytotoxic Factor
The role of aluminum in senile and presenile dementia of the Alzheimer type has been reviewed in detail elsewhere (4). However, several observations are worthy of emphasis. Neurons, in contrast to all other cell types in the body, are uniquely sensitive to the toxic effects of this trace metal. Within the neuron population not all types are equally susceptible; for ex.ample, the dorsal root ganglion cell is highly resistant to aluminum toxicity. Susceptible neuronsand human cerebral fetal neurons are among the susceptible group -appear to respond in one of two ways: A small proportion are stimulated to produce lOOA 0 filaments, chemically and immunologically identical to neurofilaments (17) , and some neurons undergo a marked inhibition of protein synthesis and die without neurofibrillary degeneration. In some brain regions with neurofibrillary degeneration in Alzheimer's disease, aluminum concentrations approaching those lethal to both cats and human cerebral neurons in tissue culture have been found. In the experimental aluminum encephalopathy with neurofibrillary degeneration and in Alzheimer's disease, aluminum is found in the nucleus in association with the acid-protein-DNA complex of chromatin. Moreover, aluminum in vitro has unique effects on DNA resulting in changes in the conformation and thermal stability of this vital molecule (4) . Nevertheless, aluminum does not induce the paired helical filaments of the Alzheimer type of neurofibrillary degeneration in human neurons and while plaque-like structures may occur, the plaques never contain amyloid (21) . Furthermore, aluminum induces neither granulovacuolar degeneration nor Hirano bodies. Aluminum may be important in processes related to the over production of neurofilaments and altered protein metabolism but other pathogenic agents must be operative to completely explain the pathology of this disease.
Increased concentrations of aluminum also occur in the brain of a progressive dementia syndrome associated with dialysis employed for renal failure. In this condition concentrations of aluminum 15 to 20 times normal occur (1) and the amount greatly exceeds that found in Alzheimer's disease or that which is lethal to cat brain. Furthermore, in dialysis patients with normal intellectual function and who die from non-neurological events, brain aluminum concentrations of 5 to 10 times normal are frequently encountered. Thus, in the dialysis encephalopathy very high levels of brain aluminum appear to be necessary before toxic manifestations occur. In addition, elevated levels of aluminum are not associated with neurofibrillary degeneration. This parodox may be related to the observation that aluminum is bound in a different tissue compartment. Recent work in our laboratory indicates that aluminum is bound in cytoplasm in dialysis brains and little, if any, reaches the nucleus. This implies that aluminum toxicity is related to the ability of cells to bind aluminum in a non-toxic form. Furthermore, our data suggest that in Alzheimer's disease aluminum gains access to the genetic apparatus of the cells either because the metal enters the brain in a form which does not evoke the cytoplasmic detoxifying mechanism or, alternatively, the detoxifying mechanism is defective as a consequence of some other manifestation of the disease.
Several promising hypotheses concerning the pathogenesis of senile and pre-senile dementia of the Alzheimer type are now available for rigorous laboratory investigation. Never before have so many promising avenues been open to investigators and significant new insights into this minddestroying disease are to be anticipated.
Summary
The most common cause of senile dementia appears to be a pathological process indistinguishable from that found in presenile dementia of the Alzheimer type. Consideration of the neuropathological changes suggest that this disease may involve the interaction of at least three processes: a viral-like infection, a disorder in the immune system and the neurotoxic effect of an environmental agent. The evidence in support of this hypothesis is reviewed.
Resume
La cause la plus commune de la dernence senile semble resider en un processus pathologique qu'on ne peut distinguer de celui rencontre dans la demence pre-senile de type Alzheimer. L'examen des changements neurophathologiques suggere qu'une interaction de trois processus peut etre impliquee: une infection de type viral, un desordre du systeme immunologique et un effet neurotoxique d'un agent dans I'environnement. On fait la revue des donnees appuyant cette hypothese.
